What Does $3.2 Billion Buy? Pharmaceutical-Biotech Industry Wraps Up Construction on 71 North American Projects
What Does $3.2 Billion Buy? Pharmaceutical-Biotech Industry Wraps Up Construction on 71 North American Projects
Attachment: IIR Chart - Pharma-Biotech Project Completed in 1Q12
SUGAR LAND--March 27, 2012--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--Theories abound regarding the Pharmaceutical-Biotech Industry, and the only fact that has emerged is it has changed and continues to do so. No construction, abundant construction, consolidation, expansion; oddly enough, all apply to this industry in transition. Sometimes, it helps to only deal with concrete facts, as in the construction concrete poured to build the 71 projects that wrapped up construction during the first quarter in North America.
Other companies featured: Cubist Pharmaceuticals (NASDAQ:CBST), Grifols USA (NASDAQ:GRFS)
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Samsung Biologics Constructing ADC Plant in South Korea
- Data Center Activity Propels Virginia to $12.7 Billion of Projects Under Co...
- Pharma Company Zoetis Signs PPA with Scout Clean Energy to Support Growing ...
- China's Rongsheng Petrochemical Ups Role in Polyester Chips
- Suffolk Construction Has Hand in $1.9 Billion Worth of Projects